Allain, H., tue-Ferrer, D., Polard, E., et al (2005) Postural instability and consequent falls and hip fractures associated with use of hypnotics in the elderly: a comparative review. Drugs and Aging, 22, 749–765.
Buscemi, N., Vandermeer, B., Hooton, N., et al (2005) The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis. Journal of General Internal Medicine, 20, 1151–1158.
Buscemi, N., Vandermeer, B., Hooton, N., et al (2006) Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. BMJ, 332, 385–393.
Dundar, Y., Dodd, S., Strobl, J., et al (2004) Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis. Human Psychopharmacology, 19, 305–322.
Erman, M., Seiden, D., Zammit, G., et al (2006) An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia. Sleep Medicine, 7, 17–24.
Espie, C. A., MacMahon, K. M., Kelly, H. L., et al (2007) Randomized clinical effectiveness trial of nurse-administered small-group cognitive behavior therapy for persistent insomnia in general practice. Sleep, 30, 574–584.
Green, A., Hicks, J. A., Weeks, R., et al (2005) A cognitive-behavioural group intervention for people with chronic insomnia: an initial evaluation. British Journal of Occupational Therapy, 68, 518–522.
Hicks, J. A., Argyropoulos, S. V., Rich, A. S., et al (2002) Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression. British Journal of Psychiatry, 180, 528–535.
Jacobs, G. D., Pace-Schott, E. F., Stickgold, R., et al (2004) Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. Archives of Internal Medicine, 164, 1888–1896.
Jansson, M. & Linton, S. J. (2005) Cognitive–behavioral group therapy as an early intervention for insomnia: a randomized controlled trial. Journal of Occupational Rehabilitation, 15, 177–190.
Kaynak, H., Kaynak, D., Gozukirmizi, E., et al (2004) The effects of trazodone on sleep in patients treated with stimulant antidepressants. Sleep Medicine, 5, 15–20.
Krystal, A. D., Walsh, J. K., Laska, E., et al (2003) Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, doubleblind, placebo-controlled study in adults with chronic insomnia. Sleep, 26, 793–799.
Morin, C. M. & Espie, C. A. (2003) Insomnia: A Clinician's Guide to Assessment and Treatment.
Morin, C. M., Bootzin, R. R., Buysse, D. J., et al (2006) Psychological and behavioral treatment of insomnia: update of the recent evidence (1998–2004). Sleep, 29, 1398–1414.
Nutt, D. J. (2005) NICE: The National Institute of Clinical Excellence – or Eccentricity? Reflections on the Z-drugs as hypnotics. Journal of Psychopharmacology, 19, 125–127.
Roth, T., Walsh, J. K., Krystal, A., et al (2005) An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia. Sleep Medicine, 6, 487–495.
Thase, M. E., Kupfer, D. J., Buysse, D. J., et al (1995) Electroencephalographic sleep profiles in single-episode and recurrent unipolar forms of major depression. I. Comparison during acute depressive states. Biological Psychiatry, 38, 506–515.
Winokur, A., DeMartinis, N. A. III, McNally, D. P., et al (2003) Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia. Journal of Clinical Psychiatry, 64, 1224–1229.